The Bioresearch Monitoring (BIMO) Program, operated by the U.S. Food and Drug Administration (FDA), conducts on-site inspections and data audits in order to effectively monitor the compliance of all ...
The U.S. Food and Drug Administration (FDA) recently announced a Request for Public Comment on the evaluation of devices that integrate artificial intelligence (AI), including generative AI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback